Patent ID: 6103709
Filing Date: 2000-08-15
Classification: A61K,C07C

Abstract:
A method for treatment of a disease connected with or caused by vitamin D.sub.3 deficiency or overproduction, by providing a subject in need of such treatment a vitamin D.sub.3 analog selected from the group consisting ofanalog LO, namely, 14.alpha.,15.alpha.-methano-1.alpha.,25(OH).sub.2 D.sub.3 ;analog EV, namely, 22-(m-dimethylhydroxymethyl) phenyl-23, 24, 25, 26, 27-pentanor-1.alpha.(OH)D.sub.3 ;analog HS, namely, 1.alpha.,18,25(OH).sub.2 D.sub.3 ;analog DE, namely, 22-(m-hydroxyphenyl)1.alpha.,25(OH)2D.sub.3 ;analog DF, namely, 22-(p-hydroxyphenyl) 1.alpha.,25(OH).sub.2 D.sub.3 ;analog IB, namely, 23-(m-dimethylhydroxymethyl) phenyl-22-yne-24, 25, 26, 27-tetranor-1.alpha.(OH)D.sub.3 ;analog JX, namely, 22-(p-hydroxyphenyl)-23, 24, 25, 26, 27-pentanor-D.sub.3 ;analog JY, namely, 22-(m-hydroxyphenyl)-23, 24, 25, 26, 27-pentanor-D.sub.3.